We are live on ! Find out more
KRON

Kronos Bio
KRON

Delisted

KRON was delisted on the 20th of June, 2025.

Back to rankings

63 hedge funds and large institutions have $39.3M invested in Kronos Bio in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 13 increasing their positions, 21 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

2.92% less ownership

Funds ownership: 54.82% → 51.9% (-2.9%)

21% less funds holding

Funds holding: 80 → 63 (-17)

28% less capital invested

Capital invested by funds: $54.3M → $39.3M (-$15M)

38% less repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 21

85% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 20

Holders
63
Holders Change
-17
Holders Change %
-21.25%
% of All Funds
1%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
3
Increased
13
Reduced
21
Closed
20
Calls
$35K
Puts
–
Net Calls
+$35K
Net Calls Change
+$5K

Top Buyers

Rank Fund Capital Flow
1
ACP
Acuta Capital Partners
California
+$652K
2
Millennium Management
Millennium Management
New York
+$572K
3
BCM
Bridgeway Capital Management
Texas
+$292K
4
BI
BVF Inc
California
+$148K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$144K

Top Sellers

Rank Fund Capital Flow
1
Cerity Partners
Cerity Partners
New York
-$730K
2
EC
EcoR1 Capital
California
-$562K
3
GCP
GSA Capital Partners
United Kingdom
-$374K
4
Charles Schwab
Charles Schwab
California
-$367K
5
Renaissance Technologies
Renaissance Technologies
New York
-$316K
Name Holding Trade Value Shares
Change 		Change in
Stake
State Street
26
State Street
Massachusetts
$232K – – –
WP
27
Woodline Partners
California
$226K – – –
Citadel Advisors
28
Citadel Advisors
Florida
$199K -$98.8K -61,150 -29%
Squarepoint
29
Squarepoint
New York
$175K -$147K -90,777 -40%
CC
30
Casdin Capital
New York
$161K – – –
KCM
31
Kennedy Capital Management
Missouri
$142K +$4.14K +2,563 +2%
Northern Trust
32
Northern Trust
Illinois
$120K -$1.53K -947 -1%
SB
33
Samsara BioCapital
California
$102K – – –
MAM
34
Marquette Asset Management
Minnesota
$88.5K – – –
GCP
35
GSA Capital Partners
United Kingdom
$71K -$374K -231,644 -81%
CBA
36
Coastal Bridge Advisors
Connecticut
$67.6K – – –
Jacobs Levy Equity Management
37
Jacobs Levy Equity Management
New Jersey
$66.1K -$7.19K -4,451 -8%
Morgan Stanley
38
Morgan Stanley
New York
$55.5K -$84.7K -52,394 -55%
CIC
39
Cornercap Investment Counsel
Georgia
$53.8K +$910 +563 +1%
FA
40
Forefront Analytics
Pennsylvania
$52K +$1.45K +900 +2%
HSBC Holdings
41
HSBC Holdings
United Kingdom
$48.3K – – –
Jane Street
42
Jane Street
New York
$41.3K +$30K +18,553 +140%
Goldman Sachs
43
Goldman Sachs
New York
$35.6K -$12K -7,413 -21%
State of Wisconsin Investment Board
44
State of Wisconsin Investment Board
Wisconsin
$29.9K -$66.1K -40,900 -64%
XT
45
XTX Topco
Cayman Islands
$27.6K -$914 -566 -3%
Bank of New York Mellon
46
Bank of New York Mellon
New York
$21.6K – – –
Charles Schwab
47
Charles Schwab
California
$21.4K -$367K -227,216 -93%
Ensign Peak Advisors
48
Ensign Peak Advisors
Utah
$21K – – –
Barclays
49
Barclays
United Kingdom
$21K – – –
PFO
50
Pathstone Family Office
New Jersey
$15.6K – – –
1
2
3 4

KRON Hedge Fund Activity: Q3 2023 in Review

63 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Kronos Bio (KRON) for Q3 2023, worth a combined $39.3M — down 28% from $54.3M a quarter earlier.

Sellers outnumbered buyers: 20 funds closed out of KRON and 3 opened new positions — a net loss of 17 holders — while 21 trimmed existing stakes and 13 added.

The largest buyer was Acuta Capital Partners, adding an estimated $652K. The largest seller was Cerity Partners, exiting entirely with an estimated $730K sold.

  • 63 institutional investors held Kronos Bio (KRON) as of Q3 2023, down from 80 in Q2 2023.
  • Funds reported $39.3M of Kronos Bio stock for Q3 2023, down 28% quarter-over-quarter.
  • 3 funds opened new Kronos Bio positions in Q3 2023 and 20 closed out, a net change of -17 holders.
  • The largest Kronos Bio buyer in Q3 2023 was Acuta Capital Partners, an estimated $652K added.
  • The largest Kronos Bio seller in Q3 2023 was Cerity Partners, an estimated $730K sold.

Based on aggregated 13F filings for Q3 2023.